These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 29697804)
1. Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years. Vermeulen JM; van Rooijen G; van de Kerkhof MPJ; Sutterland AL; Correll CU; de Haan L Schizophr Bull; 2019 Mar; 45(2):315-329. PubMed ID: 29697804 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study. Kelly DL; McMahon RP; Liu F; Love RC; Wehring HJ; Shim JC; Warren KR; Conley RR J Clin Psychiatry; 2010 Mar; 71(3):304-11. PubMed ID: 20079332 [TBL] [Abstract][Full Text] [Related]
3. [Leponex, 10 years after -- a clinical review]. Llorca PM; Pere JJ Encephale; 2004; 30(5):474-91. PubMed ID: 15627052 [TBL] [Abstract][Full Text] [Related]
4. Clozapine versus typical neuroleptic medication for schizophrenia. Wahlbeck K; Cheine M; Essali MA Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289 [TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland. Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224 [TBL] [Abstract][Full Text] [Related]
6. Causes of death in clozapine-treated patients in a catchment area: a 10-year retrospective case-control study. Rose E; Chen S; Turrion C; Jenkins C; Cardinal RN; Fernandez-Egea E Eur Neuropsychopharmacol; 2020 Jul; 36():160-166. PubMed ID: 32546415 [TBL] [Abstract][Full Text] [Related]
7. Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. De Hert M; Correll CU; Cohen D Schizophr Res; 2010 Mar; 117(1):68-74. PubMed ID: 20060684 [TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
9. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482 [TBL] [Abstract][Full Text] [Related]
10. Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis. Vermeulen J; van Rooijen G; Doedens P; Numminen E; van Tricht M; de Haan L Psychol Med; 2017 Oct; 47(13):2217-2228. PubMed ID: 28397632 [TBL] [Abstract][Full Text] [Related]
11. Metabolic predictors for mortality among patients treated with long-term clozapine - A longitudinal study. Taub S; Hoshen M; Balicer R; Kamhi-Nesher S; Weizman A; Krivoy A Eur Neuropsychopharmacol; 2020 Dec; 41():63-69. PubMed ID: 32981820 [TBL] [Abstract][Full Text] [Related]
12. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447 [TBL] [Abstract][Full Text] [Related]
13. Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials. Schneider-Thoma J; Efthimiou O; Huhn M; Krause M; Reichelt L; Röder H; Davis JM; Salanti G; Leucht S Lancet Psychiatry; 2018 Aug; 5(8):653-663. PubMed ID: 30042077 [TBL] [Abstract][Full Text] [Related]
14. Suicidal risk during treatment with clozapine: a meta-analysis. Hennen J; Baldessarini RJ Schizophr Res; 2005 Mar; 73(2-3):139-45. PubMed ID: 15653256 [TBL] [Abstract][Full Text] [Related]
15. Zotepine versus other atypical antipsychotics for schizophrenia. Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Kissling W; Leucht S Cochrane Database Syst Rev; 2010 Jan; (1):CD006628. PubMed ID: 20091601 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects of antipsychotics on mortality in patients with schizophrenia: a systematic review and meta-analysis. Jia N; Li Z; Li X; Jin M; Liu Y; Cui X; Hu G; Liu Y; He Y; Yu Q Braz J Psychiatry; 2022 Nov; 44(6):664-673. PubMed ID: 36709510 [TBL] [Abstract][Full Text] [Related]
17. Risperidone versus other atypical antipsychotic medication for schizophrenia. Gilbody SM; Bagnall AM; Duggan L; Tuunainen A Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551 [TBL] [Abstract][Full Text] [Related]
18. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies. Masuda T; Misawa F; Takase M; Kane JM; Correll CU JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048 [TBL] [Abstract][Full Text] [Related]
19. Clozapine for the treatment of schizophrenia. Fakra E; Azorin JM Expert Opin Pharmacother; 2012 Sep; 13(13):1923-35. PubMed ID: 22803789 [TBL] [Abstract][Full Text] [Related]
20. [Screening of adults with schizophrenia for metabolic complications caused by atypical antipsychotics]. Cohen D Tijdschr Psychiatr; 2010; 52(2):111-5. PubMed ID: 20146182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]